AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer

This study is ongoing, but not recruiting participants.

Study NCT00770848 Information provided by Amgen

First Received: October 9, 2008 Last Updated: September 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2012
Estimated Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)